IMCY-T1D-002: Long-term Follow-up Study of T1D Patients Previously Treated With IMCY-0098 or Placebo
Condition(s):Type 1 Diabetes MellitusLast Updated:May 2, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Type 1 Diabetes MellitusLast Updated:May 2, 2022Completed
Condition(s):Type 1 DiabetesLast Updated:January 11, 2022Completed
Condition(s):Type 1 DiabetesLast Updated:February 13, 2014Unknown status
Condition(s):Type 1 DiabetesLast Updated:January 7, 2016Completed
Condition(s):Type 1 Diabetes MellitusLast Updated:July 16, 2013Unknown status
Condition(s):Type1diabetesLast Updated:November 12, 2019Completed
Condition(s):Type 1 DiabetesLast Updated:April 25, 2022Completed
Condition(s):Type 1 DiabetesLast Updated:February 13, 2014Completed
Condition(s):Type 1 Diabetes; Autoimmune Diseases; Hashimoto Disease; Graves Disease; Celiac Disease; Addison Disease; VitiligoLast Updated:March 30, 2021Unknown status
Condition(s):Type 1 DiabetesLast Updated:May 23, 2022Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.